While a relatively small sum of revenue it does bode well for the company. It's not often you find a biotech with a decent opportunity for a revenue stream to supplement the big potential payoff.
Curious as to wiser heads' views on the revenue potential for PIQ's analytical services business?
Ann: Proteomics secures major analytical services contract, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.005(1.41%) |
Mkt cap ! $58.86M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 35.5¢ | $116.7K | 323.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 13166 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 113491 | 3 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |